Canopy Growth Corporation (TSX: WEED) (“Canopy Growth” or “the Company”) is pleased to welcome PUF Ventures Inc. (CSE:PUF, Frankfurt:PU3), a London, Ontario-based late-stage ACMPR applicant, to the Tweed Main Street curated CraftGrow line.
Pending a license to cultivate and sell cannabis products, PUF will become the fourth company to join CraftGrow. The program
By Pia Rivera
OK2 Minerals Ltd. (TSX VENTURE:OK) (the “Company” or “OK2”) is pleased to announce the mobilization of the field crews to begin the 2017 exploration program on the Pyramid Cu/Au project at the northern tip of BC’s “Golden Triangle”.
The large Pyramid project was staked in 2013 and now after four seasons
The deal is valued at about C$590 million, and will give Eldorado a toehold in Canada’s Eastern Abitibi region.
Prometic Life Sciences will present new data on the benefits of plasminogen administration to reduce lung injury in animal model associated with acute pancreatitis.
OK2 Minerals (TSXV:OK) is pleased to announce it has signed contracts with two drilling contractors for the upcoming 2017 field season at its 100% owned Pyramid copper-gold project, located north of Dease Lake, at the northern tip of B. C’s “Golden Triangle”.
American CuMo Mining Corporation (TSXV:MLY,OTCPINK:MLYCF) announces that its wholly-owned subsidiary, Idaho CuMo Mining Corporation (Idaho CuMo), has completed an option to purchase agreement for thirty-six (36) patented mining claims, covering an area of approximately 640 acres adjacent to the CuMo Project. Patented claims contain the surface rights as well as
Algold Resources Ltd. (TSXV:ALG) today announced more preliminary assay results from its Phase III 20,000-meter drilling campaign carried out on its Tijirit property (“Tijirit”) in Mauritania. The results continue to demonstrate the high-grade nature of the Eleonore zone and extend the mineralized horizons in the South and Central zones.
Invictus MD (TSXV:IMH) is pleased to announce that AB Laboratories Inc. (“AB Labs”), a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), will provide their unique products in Canopy Growth Corporation’s (TSX:WEED) (“Canopy Growth”) curated CraftGrow line on Tweed Main Street’s online store, that brings high
Invictus MD (TSXV:IMH) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 82.5%, has generated $1.787 million in revenue for the 9 months ending March 31, 2017, with a gross margin of $907,864, representing a 50.8% gross margin compared to the same
Acreage Pharms Ltd., which Invictus MD (CNX:IMH). has the option to now acquire 100 per cent of and expects to exercise in short order, has begun its new cultivation cycle, having received its licence to cultivate under the access to cannabis for medical purposes regulations (ACMPR); Acreage is firmly committed
Cytori Therapeutics received approval from the US Food and Drug Administration for a burn clinical trial using the Cytori Cell Therapy.
Algold Resources Ltd. (TSXV:ALG) today released preliminary assay results from its phase 3 20,000-metre drilling campaign carried out on its Tijirit property in Mauritania. Results continue to demonstrate the high-grade nature of the Eleonore zone, with the mineralization now extending to a vertical depth of up to 150 metres.
Invictus MD (CNX:IMH), Canada’s cannabis company, is pleased to announce that its common shares will be delisted from the Canadian Securities Exchange after the close of trading on March 30, 2017 and will be listed on the TSX Venture Exchange (“TSXV”) commencing at the open of trading on March 31,
Invictus MD Strategies Corp. CNX:IMH) is providing an update of its production capability in preparation for the recreational cannabis market.
Marijuana could be legal in Canada by July 1, 2018; according to CBC News, it has learned that the legislation will be announced during the week of April 10 and will
Invictus MD (CNX:IMH) is pleased to announce it has received conditional approval to list its common shares for trading on the TSX Venture Exchange.
Invictus MD (CNX:IMH) – Mr. Kveton is a highly effective, strategic and pragmatic international executive and investment professional, with broad experience operating in both Fortune 500 and start-up environments. He has a proven record in generating top-line growth by executing cross-border merger and acquisition deals and transformations to a high